Clinical Deep Dives

PSYCH 009: Novel Neurotransmitters

For decades, psychiatry has centred on a core set of neurotransmitters - dopamine, serotonin, noradrenaline. Yet the brain’s chemical language is far richer than once imagined. This chapter explores emerging and “novel” neurotransmitters that challenge traditional models and open new pathways for understanding and treatment. In this episode, we examine systems such as glutamatergic modulation beyond classical pathways, endocannabinoids, nitric oxide, and other unconventional signalling molecules. These do not always conform to the standard rules of neurotransmission - some act retrogradely, some diffuse freely, and others influence entire systems without clear synaptic boundaries. We explore how these systems contribute to plasticity, perception, mood regulation, and stress response. Their roles are often subtle but profound - shaping how signals are filtered, integrated, and prioritised. Importantly, these discoveries are reshaping psychiatric treatment. The emergence of agents targeting glutamate systems, for example, has transformed approaches to conditions such as depression, moving beyond traditional monoamine frameworks. This chapter represents a frontier - a reminder that our current models are incomplete, and that the biology of the mind is still being uncovered. Key Takeaways * Novel neurotransmitters expand beyond classical monoamine and amino acid systems. * These include endocannabinoids, nitric oxide, and advanced glutamatergic mechanisms. * Some act in unconventional ways (e.g. retrograde signalling, diffusion-based transmission). * They play roles in plasticity, mood regulation, perception, and stress response. * These systems challenge traditional models of neurotransmission. * Emerging treatments increasingly target these pathways (e.g. glutamate modulation). * Psychiatry is evolving as new biological mechanisms are discovered. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe [https://drmanaankarray.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_2]

PSYCH 008: Neuropeptides: Biology, Regulation and Role in Neuropsychiatric Disorders

Beyond fast neurotransmission lies a quieter, more sustained form of communication. Neuropeptides do not simply transmit signals - they shape the context in which those signals are interpreted. This chapter explores a class of molecules that operate over longer timescales, influencing emotion, stress, bonding, and behavioural states. In this episode, we examine how neuropeptides such as CRH, oxytocin, vasopressin, and endogenous opioids act as modulators of internal experience. Unlike classical neurotransmitters, their effects are slower, more diffuse, and often longer-lasting - altering the tone of entire systems rather than moment-to-moment signalling. We explore their central role in stress regulation, particularly through the hypothalamic–pituitary–adrenal (HPA) axis, and how dysregulation can contribute to anxiety, depression, and trauma-related conditions. Neuropeptides also shape social behaviour - influencing attachment, trust, and interpersonal sensitivity. Crucially, these systems blur the boundary between biology and meaning. They encode not just signals, but significance - linking physiological states to emotional and relational experience. This chapter invites a different lens: to see psychiatric disorders not only as disturbances of fast signalling, but as alterations in the deeper, slower currents that shape how the world feels over time. Key Takeaways * Neuropeptides act as slow, modulatory signalling molecules in the brain. * Their effects are longer-lasting and more diffuse than classical neurotransmitters. * They play key roles in stress regulation, particularly via the HPA axis. * Neuropeptides influence social behaviours such as attachment, bonding, and trust. * Systems involving CRH, oxytocin, vasopressin, and endogenous opioids are central to emotional regulation. * Dysregulation contributes to anxiety, depression, trauma-related disorders, and social dysfunction. * Neuropeptides link physiological states to subjective emotional experience. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe [https://drmanaankarray.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_2]

PSYCH 007: Biogenic Amine Neurotransmitters

If amino acid neurotransmitters set the basic tone of brain activity, biogenic amines shape its nuance. This chapter explores the neurotransmitter systems that modulate how we feel, think, and act - particularly dopamine, serotonin, and noradrenaline. In this episode, we examine how these systems do not simply transmit signals, but regulate them. They influence mood, reward, motivation, attention, arousal, and stress responses - acting as global tuning systems that adjust the brain’s overall state. We explore dopamine as a mediator of salience and reward prediction, serotonin as a regulator of mood and emotional stability, and noradrenaline as a driver of alertness and adaptive response to challenge. These systems are widely projecting, originating in small brainstem nuclei but influencing vast cortical and subcortical networks. Crucially, dysfunction in these modulatory systems does not produce isolated symptoms, but shifts in how the brain interprets and responds to the world. Depression, anxiety, psychosis, and addiction can all be understood, in part, as alterations in these tuning mechanisms. This chapter provides a bridge between biology and experience - showing how subtle changes in neurochemistry can reshape perception, motivation, and meaning itself. Key Takeaways * Biogenic amines (dopamine, serotonin, noradrenaline) modulate brain function rather than directly drive signalling. * These systems influence mood, motivation, attention, arousal, and stress responses. * Dopamine is central to reward, salience, and prediction error. * Serotonin regulates mood, emotional balance, and behavioural inhibition. * Noradrenaline governs alertness, vigilance, and response to stress. * These neurotransmitters originate in small nuclei but project widely across the brain. * Dysregulation leads to shifts in perception and behaviour rather than isolated deficits. * Many psychiatric treatments target these systems to restore functional balance. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe [https://drmanaankarray.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_2]

PSYCH 006: Amino Acid Neurotransmitters

At the heart of neural communication lie a small group of powerful molecules that set the tone of brain activity. This chapter focuses on amino acid neurotransmitters - particularly glutamate and GABA - which together form the fundamental balance between excitation and inhibition. In this episode, we explore how glutamate drives neural activation, enabling signalling, plasticity, and learning, while GABA provides restraint, stabilising circuits and preventing excessive activity. The brain depends on this delicate equilibrium - too much excitation risks instability, too much inhibition risks suppression. We examine how these neurotransmitters act through different receptor systems, shaping both rapid signalling and longer-term modulation. Their influence extends across virtually all brain systems, making them central to both normal function and pathology. Disruptions in this balance are implicated in a wide range of psychiatric conditions - from anxiety and epilepsy to schizophrenia and mood disorders. Rather than isolated dysfunctions, these represent shifts in the overall tone of neural networks. This chapter reframes brain activity as a dynamic negotiation - a continuous balancing act that allows complexity without chaos. Key Takeaways * Amino acid neurotransmitters (primarily glutamate and GABA) are central to brain function. * Glutamate is the main excitatory neurotransmitter; GABA is the main inhibitory neurotransmitter. * Brain function depends on a precise balance between excitation and inhibition. * Different receptor types mediate fast and slow signalling effects. * These systems are widely distributed and influence most neural circuits. * Dysregulation of excitation–inhibition balance is implicated in multiple psychiatric disorders. * Understanding this balance is key to interpreting both symptoms and treatments. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe [https://drmanaankarray.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_2]

PSYCH 005: Cellular and Synaptic Basis of Neural Signalling

Beneath every thought, emotion, and behaviour lies a fundamental process: communication between neurons. This chapter explores how individual brain cells generate, transmit, and modulate signals - forming the basis of all mental activity. In this episode, we examine the neuron as both an electrical and chemical entity. Electrical signals travel along axons as action potentials, while communication between neurons occurs at synapses through the release of neurotransmitters. This dual system allows for both speed and flexibility. We explore how synaptic transmission is not simply a relay, but a point of modulation. Signals can be amplified, dampened, or reshaped depending on receptor types, neurotransmitter availability, and downstream intracellular processes. The brain is therefore not a fixed circuit, but a constantly adjusting system. Plasticity emerges as a central theme - the ability of synapses to strengthen or weaken over time. This underpins learning, memory, and adaptation, but also contributes to dysfunction when regulation goes awry. Understanding these processes provides a mechanistic foundation for psychiatry. Many treatments - from medications to neuromodulation - ultimately act by altering signalling at the synaptic level. This chapter invites a shift in perspective: to see symptoms not just as experiences, but as patterns of signalling - altered conversations between cells. Key Takeaways * Neural signalling involves both electrical (action potentials) and chemical (synaptic transmission) processes. * Synapses are active sites of modulation, not passive relays. * Neurotransmitters interact with specific receptors to shape downstream effects. * Intracellular signalling pathways influence how signals are processed and adapted. * Synaptic plasticity underlies learning, memory, and behavioural change. * Dysregulation of signalling contributes to psychiatric disorders. * Many psychiatric treatments act by modifying synaptic transmission and plasticity. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe [https://drmanaankarray.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_2]